Anzeige
Mehr »
Login
Sonntag, 19.09.2021 Börsentäglich über 12.000 News von 674 internationalen Medien
Rekord-Handelsvolumen mit gewaltigem Wachstum & Launch neuer Fiat zu Krypto Plattform!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PK7M ISIN: SE0012673291 Ticker-Symbol: MN2 
Frankfurt
17.09.21
08:07 Uhr
13,800 Euro
-0,650
-4,50 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MENTICE AB Chart 1 Jahr
5-Tage-Chart
MENTICE AB 5-Tage-Chart
PR Newswire
337 Leser
Artikel bewerten:
(2)

Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office

STOCKHOLM, Dec. 4, 2020 /PRNewswire/ -- Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28.

The total number of shares in Mentice AB after registration with the Swedish Companies Registration Office amounts to 24,727,995 shares. Through the issuance of new shares, the share capital in Mentice AB has increased to SEK 1,236,399.75.

For details on the acquisitions, please refer to press releases dated October 1, 2020 and October 8, 2020.

For more information, please contact:

Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice

Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions. More information on www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mentice-ab/r/issuance-of-new-shares-in-mentice-ab--publ--has-been-registered-with-the-swedish-companies-registrat,c3249537

The following files are available for download:

https://mb.cision.com/Main/18275/3249537/1344486.pdf

Release

MENTICE-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.